Candidate gene studies of human pain mechanisms - Methods for optimizing choice of polymorphisms and sample size
Candidate gene studies of human pain mechanisms - Methods for optimizing choice of polymorphisms and sample size
复制标题
DOI:
10.1097/00000542-200406000-00032
复制
发表时间:
2004-06-01
期刊:
影响因子:
8.8
通讯作者:
Max, MB
中科院分区:
文献类型:
--
作者:
Belfer, I;Wu, TX;Max, MB
THE elucidation of the human genome and proteome offers the clinical researcher the opportunity to test thousands of hypotheses in a single study. 1 Clinical researchers in established areas such as oncology, diabetes, and cardiovascular disease have seized this opportunity. For example, PubMed searches of the disease name with the terms polymorphism and human yield more than 10,000 citations for cancer and 2,000 for diabetes or hypertension. Although there are many studies examining the genetic risk factors for variations in macroscopic structural disease that may trigger pain—eg, coronary stenosis, rheumatoid arthritis, or lumbar disc herniation—clinical pain researchers have made little use of these genomic riches to study variations in pain processing, given a uniform initiating injury. The plausibility of clinical pain genetic studies is supported by the recent findings of major differences between inbred mouse strains in the behavioral response to more than 20 different acute and chronic pain conditions, including thermal and chemical stimulation of the skin and viscera and nerve injury. 2–4 These results suggest that genetic variants affecting pain processing are common and conserved in mammalian populations. Perhaps pain researchers have neglected clinical genetics because, apart from a few rarities, 5, 6 they have not noticed obvious familial inheritance of pain syndromes. However, familial inheritance only becomes obvious for alleles conferring a relative risk (RR) of 50 or more. Association studies, in which the frequencies of common allelic variants are compared in cases and controls, may detect relatively small increases in RR. Such studies have detected alterations in RR in Alzheimer disease, Crohn disease, venous thrombosis, diabetes, schizophrenia, osteoporotic fractures, and other common medical disorders. 7Allele-based association studies differ from locus-based family genetic studies in several ways. In family studies, in which the subjects share whole chromosomes or large portions thereof, several hundred genetic markers through the chromosome are sufficient to search the entire genome for a susceptibility locus. Several markers will be on the same preserved chromosome fragment as the disease susceptibility gene. Association studies are generally performed in unrelated individuals in whom only short segments of DNA are shared, so the density of markers studied over any length of DNA must be up to 1,000 times greater than in family studies. Conversely, two advantages of association studies are that they have greater power than family linkage studies to detect genetic effects of slight to modest size, 8 and one has broad latitude in selecting unrelated subjects in a way to optimize the clinical phenotype and to standardize environmental exposures and measurement methods. Genetic association studies lend themselves to the study of the most perplexing problem in pain research, that after apparently identical structural injuries to a variety of tissues, pain resolves rapidly in most patients and persists in others. Well-studied examples include shingles, diabetic neuropathy, spinal degeneration, limb amputation, mastectomy, thoracotomy, or whiplash injury. Only a small part of the variance in pain persistence has been explained by age, severity of the injury, per-